Plain-English translation of NCT07062094 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This trial is testing the Orbera365 intragastric balloon, a small balloon that is swallowed and placed in your stomach to help you feel fuller and lose weight. The study is tracking how safe this device is when it stays in your stomach for a longer period—up to 12 months instead of the usual 6 months. Researchers want to confirm that it works well and doesn't cause serious problems over this extended time.
Many people find it very hard to lose weight through diet and exercise alone. This treatment offers an option for people with obesity who have already tried other weight-loss programs without success, and it may also help reduce surgical risk for people who need obesity-related surgery.
You likely qualify if…
You likely don't qualify if…
You would have the balloon placed in your stomach during a brief procedure, then wear it for up to 12 months while following a weight-loss program with your doctor's support. During this time, you'll need to take a specific medication to protect your stomach and attend follow-up visits to check how you're doing. After the balloon is removed, you'll have one more check-in 30 days later, and your total time in the study will be about 13 months from start to finish.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Czechia
France
Spain
United Kingdom